Immunic, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -73.1% | -73.1% | -66.8% |
| FY2022 | -105.9% | -105.9% | -94.2% |
| FY2023 | -323.6% | -323.6% | -172.4% |
| FY2024 | -545.4% | -545.4% | -245.9% |
| FY2025 | 1,456.2% | 1,456.2% | -404.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -73.1% | -73.1% | -66.8% |
| FY2022 | -105.9% | -105.9% | -94.2% |
| FY2023 | -323.6% | -323.6% | -172.4% |
| FY2024 | -545.4% | -545.4% | -245.9% |
| FY2025 | 1,456.2% | 1,456.2% | -404.0% |